Patients with cirrhosis who undergo placement of a transjugular intrahepatic portosystemic shunt (TIPS) may benefit from treatment with rifaximin before and after the procedure, according to a recent randomized controlled trial. ... Results of the trial
Results were published online on Oct. 13 as a brief research report by Annals of Internal Medicine. ... In cases with visual inspection only, 95% of potential surprise bills involved anesthesiologists.
Median follow-up was 14.8 years. Results were published by Annals of Internal Medicine on April 24. ... Similarly, men saw a decrease in risk of colorectal cancer mortality with screening (0.49% vs.
An In the Clinic article in the Nov. 6 Annals of Internal Medicine provides an evidence-based, clinically relevant overview of the diagnosis and treatment of nonalcoholic fatty liver disease. ... The editors of Annals of Internal Medicine develop In the
https://gastroenterology.acponline.org/archives/2019/02/22/7.htm. Physicians from Beth Israel Deaconess Medical Center in Boston discuss the care of a patient with recurrent acute pancreatitis who decides ... In the Beyond the Guidelines section of the
The results of the study, which was funded by Merck, were published by Annals of Internal Medicine on Aug. ... 7. Of the 20 patients included in the study, 70% were men and 40% were black.
The study results were published Aug. 14 by Annals of Internal Medicine. ... CAD was used to assess a total of 466 diminutive polyps from 325 patients (median age, 67 years; 72.3% men).
Annals of Internal Medicine has released Series 11 of Annals Virtual Patients, featuring a case on irritable bowel syndrome. ... Cases are available at a discount to ACP members and Annals of Internal Medicine subscribers.
Researchers performed a systematic review and meta-analysis of 42 clinical trials published through Nov. ... The study results were published online March 21 by Annals of Internal Medicine.
than 15 years of age, had recently started treatment with either drug, and had no other indications for infliximab. ... 11 by Annals of Internal Medicine. A total of 5,050 patients were included in the study, 2,551 who were taking infliximab and 2,499